Sharma B, Chalikwar R, Bhalerao S, Gondane A, Pawar D, Sharma A
Cureus. 2024; 16(9):e69146.
PMID: 39398799
PMC: 11467699.
DOI: 10.7759/cureus.69146.
Garnier A, Drablier G, Briet M, Augusto J
Drug Saf. 2023; 46(8):715-724.
PMID: 37310614
DOI: 10.1007/s40264-023-01316-1.
Louta A, Kanellopoulou A, Alexopoulou Prounia L, Filippas M, Tsami F, Vlachodimitropoulos A
J Pers Med. 2023; 13(4).
PMID: 37109057
PMC: 10142585.
DOI: 10.3390/jpm13040671.
Bhaumik K
J Indian Assoc Pediatr Surg. 2021; 26(4):228-233.
PMID: 34385765
PMC: 8323576.
DOI: 10.4103/jiaps.JIAPS_107_20.
Yoshida R, Yoshizako T, Katsube T, Kitagaki H
Jpn J Radiol. 2019; 37(12):826-831.
PMID: 31654330
DOI: 10.1007/s11604-019-00893-5.
Drug-Induced Urolithiasis in Pediatric Patients.
Sighinolfi M, Eissa A, Bevilacqua L, Zoeir A, Ciarlariello S, Morini E
Paediatr Drugs. 2019; 21(5):323-344.
PMID: 31541411
DOI: 10.1007/s40272-019-00355-5.
Ceftriaxone-associated nephrolithiasis and gallstone in adults.
Azarkar G, Birjand M, Ehsanbakhsh A, Bijari B, Abedini M, Ziaee M
Drug Healthc Patient Saf. 2018; 10:103-108.
PMID: 30588126
PMC: 6296198.
DOI: 10.2147/DHPS.S183892.
Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment.
Daudon M, Frochot V, Bazin D, Jungers P
Drugs. 2017; 78(2):163-201.
PMID: 29264783
DOI: 10.1007/s40265-017-0853-7.
A symptomatic child with ceftriaxone-associated biliary pseudolithiasis.
Kutuya N, Ozaki Y, Okazaki T
J Med Ultrason (2001). 2016; 35(3):125-8.
PMID: 27278835
DOI: 10.1007/s10396-008-0170-6.
Characterizing ceftriaxone-induced urolithiasis and its associated acute kidney injury: an animal study and Chinese clinical systematic review.
Zhang Y, Ning B, Zhu H, Cong X, Zhou L, Wang Q
Int Urol Nephrol. 2016; 48(7):1061-9.
PMID: 27126355
DOI: 10.1007/s11255-016-1273-4.
Hypercalciuria following ceftriaxone a fact or myth.
Azarfar A, Esmaeeli M, Ravanshad Y, Bagheri S, Khodashenas E, Ghane-Sharbaf F
J Renal Inj Prev. 2015; 4(3):101-3.
PMID: 26468483
PMC: 4594212.
DOI: 10.12861/jrip.2015.20.
Adverse reaction to ceftriaxone in a 28-day-old infant undergoing urgent craniotomy due to epidural hematoma: review of neonatal biliary pseudolithiasis.
Bartkowska-Sniatkowska A, Jonczyk-Potoczna K, Zielinska M, Rosada-Kurasinska J
Ther Clin Risk Manag. 2015; 11:1035-41.
PMID: 26170682
PMC: 4494631.
DOI: 10.2147/TCRM.S79419.
Ceftriaxone-associated nephrolithiasis in children.
Fesharakinia A, Ehsanbakhsh A, Ghorashadizadeh N
Iran J Pediatr. 2014; 23(6):643-7.
PMID: 24910741
PMC: 4025120.
Acute kidney injury caused by ceftriaxone-induced urolithiasis in children: a single-institutional experience in diagnosis, treatment and follow-up.
Shen X, Liu W, Fang X, Jia J, Lin H, Xu M
Int Urol Nephrol. 2014; 46(10):1909-14.
PMID: 24879561
DOI: 10.1007/s11255-014-0742-x.
Early-onset neonatal sepsis.
Simonsen K, Anderson-Berry A, Delair S, Davies H
Clin Microbiol Rev. 2014; 27(1):21-47.
PMID: 24396135
PMC: 3910904.
DOI: 10.1128/CMR.00031-13.
Increasing urinary calcium excretion after ceftriaxone and cephalothin therapy in adults: possible association with urolithiasis.
Otunctemur A, Ozbek E, Polat E, Cekmen M, Dursun M, Cakir S
Urolithiasis. 2013; 42(2):105-8.
PMID: 24310104
DOI: 10.1007/s00240-013-0627-y.
Anuria and abdominal pain induced by ceftriaxone-associated ureterolithiasis in adults.
Li Z, Li H, Chen H, Li H, Zhang P, Wang Z
Int Urol Nephrol. 2012; 45(1):73-6.
PMID: 23180444
DOI: 10.1007/s11255-012-0330-x.
Gallbladder pseudolithiasis caused by ceftriaxone in young adult.
Choi Y, Jung Y, Choi S, Lee C, Kim D, Hur K
J Korean Surg Soc. 2011; 81(6):423-6.
PMID: 22200045
PMC: 3243861.
DOI: 10.4174/jkss.2011.81.6.423.
Ceftriaxone associated urolithiasis in a child with hypercalciuria.
Lozanovski V, Gucev Z, Avramoski V, Kirovski I, Makreski P, Tasic V
Hippokratia. 2011; 15(2):181-3.
PMID: 22110305
PMC: 3209686.
Nephrolithiasis caused by ceftriaxone in a 3-year-old child with ureteropelvic junction obstruction.
Stojanovic V, Djuric Vijatov G
Case Rep Med. 2009; 2009:365962.
PMID: 19718430
PMC: 2729447.
DOI: 10.1155/2009/365962.